Key Publications

Alavi M.V. 2022 Recent advances in, and challenges of, designing OMA1 drug screens. Pharmacol Res. 6:106063. PMID: 34999225.

Alavi M.V. 2021 OMA1 High-Throughput Screen Reveals Protease Activation by Kinase Inhibitors. ACS Chem Biol. 16(11):2202-2211. PMID: 34672515.

Alavi M.V. 2021 Tau phosphorylation and OPA1 proteolysis are unrelated events: Implications for Alzheimer's Disease. Biochim Biophys Acta Mol Cell Res. 1868(12):119116. PMID: 34400172.

Alavi M.V. 2021 OMA1-An integral membrane protease? Biochim Biophys Acta Proteins Proteom. 1869(2):140558. PMID: 33130089.

Alavi M.V. 2019 Targeted OMA1 therapies for cancer. Int J Cancer. 145(9):2330-2341. PMID: 30714136.

Alavi M.V. & Fuhrmann N. 2013 Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics. Mol Neurodegener. 8:32. PMID: 24067127.